Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

Ying Chen,Rui Li,Yuqi Zhu,Sixia Zhong,Jinjun Qian,Dongqing Yang,Artur Jurczyszyn,Meral Beksac,Chunyan Gu,Ye Yang

DOI: https://doi.org/10.3389/fonc.2021.736373

IF: 4.7

2021-07-23

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00767.].

oncology

What problem does this paper attempt to address?

[Corrigendum] Dihydroartemisinin Suppresses Proliferation, Migration, the Wnt/β‑catenin Pathway and EMT Via TNKS in Gastric Cancer

Yanmei Ma,Peng Zhang,Qilong Zhang,Xiaofei Wang,Qiong Miao,Xiaolan Lyu,Bo Cui,Honghong Ma

DOI: https://doi.org/10.3892/ol.2021.13152

2021-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2021.12949.].
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu,Mengxia Yu,Yanling Ren,Kongfei Li,Dominic M. Maggio,Chen Mei,Li Ye,Juying Wei,Jie Jin,Zhengping Zhuang,Hongyan Tong

DOI: https://doi.org/10.1038/s41598-017-14858-z

IF: 4.6

2017-01-01

Scientific Reports

Abstract:correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Correction: Corrigendum: Dihydroartemisinin Prevents Breast Cancer-Induced Osteolysis Via Inhibiting Both Breast Cancer Cells and Osteoclasts

Ming-Xuan Feng,Jian-Xin Hong,Qiang Wang,Yong-Yong Fan,Chi-Ting Yuan,Xin-Huan Lei,Min Zhu,An Qin,Hai-Xiao Chen,Dun Hong

DOI: https://doi.org/10.1038/srep46935

IF: 4.6

2018-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 19074; published online: 08 January 2016; updated: 08 January 2018 The original version of this Article contained an error in the title of the paper, where the word “cancer” was incorrectly given as “caner”. This has now been corrected in the PDF and HTML versions of the Article.
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction

Huimin Yan,Jia Lu,Jiabao Wang,Lu Chen,Yu Wang,Lin Li,Lin Miao,Han Zhang

DOI: https://doi.org/10.3389/fphar.2021.808424

IF: 5.6

2022-01-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.730567.].

pharmacology & pharmacy
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Huan Shi,Xin-Yu LI,Yao Chen,Xing Zhang,Yong Wu,Zi-Xuan Wang,Pan-Hong Chen,Hui-Qi Dai,Ji Feng,Sayantan Chatterjee,Zhong-Jie Li,Xiao-Wei Huang,Hong-Qiao Wei,Jigang Wang,Guo-Dong Lu,Jing Zhou

DOI: https://doi.org/10.3389/fphar.2020.640750

IF: 5.6

2021-02-08

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.534171.].

pharmacology & pharmacy
Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Xu Zhang,Jie Wang,Yifeng Wang,Guanzheng Liu,Huan Li,Jiefeng Yu,Runqiu Wu,Jun Liang,Rutong Yu,Xuejiao Liu

DOI: https://doi.org/10.3389/fonc.2022.911817

IF: 4.7

2022-04-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.608082.].

oncology
Corrigendum to “Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2”

Cuiping Guan,Qingtian Li,Xiuzu Song,Wen Xu,Liuyu Li,Aie Xu

DOI: https://doi.org/10.1155/2020/1402346

2020-10-19

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2017/9303054.].

cell biology
Correction: Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl

Juliano D. Paccez,Kristal Duncan,Durairaj Sekar,Ricardo G. Correa,Yihong Wang,Xuesong Gu,Manoj Bashin,Kelly Chibale,Towia A. Libermann,Luiz F. Zerbini

DOI: https://doi.org/10.1038/s41389-024-00533-2

2024-09-14

Oncogenesis

Abstract:Oncogenesis, Published online: 12 September 2024; doi:10.1038/s41389-024-00533-2 Correction: Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl

oncology
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Xu Wang,Renjie Hui,Yun Chen,Wentao Wang,Yujiao Chen,Xiaohai Gong,Jian Jin

DOI: https://doi.org/10.3389/fphar.2020.603491

IF: 5.6

2020-11-26

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.01434.].

pharmacology & pharmacy
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Xiu-Ying He,Yang Xu,Qing-Jie Xia,Xiao-Ming Zhao,Shan Li,Xiao-Qiong He,Ru-Rong Wang,Ting-Hua Wang

DOI: https://doi.org/10.3389/fonc.2022.872110

IF: 4.7

2022-03-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.663262.].

oncology
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei,Juanjuan Shi,Qianhan Lin,Xiaoxue Ma,Yingxin Pang,Hongluan Mao,Rui Li,Wei Lu,Yu Wang,Peishu Liu

DOI: https://doi.org/10.3389/fonc.2021.742374

IF: 4.7

2021-09-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.642229.].

oncology
Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2022.1008088

IF: 5.5

2022-09-23

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00840.].

cell biology,developmental biology
Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Dongli Yue,Daiqun Zhang,Xiaojuan Shi,Shasha Liu,Anqi Li,Dong Wang,Guohui Qin,Yu Ping,Yamin Qiao,Xinfeng Chen,Feng Wang,Renyin Chen,Song Zhao,Lidong Wang,Yi Zhang

DOI: https://doi.org/10.3389/fonc.2022.860158

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00311.].

oncology
Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li,Weihua Yuan,Shufang Bin,Guang Wu,Panyuan Li,Min Liu,Jifeng Yang,Xiang Li,Kaiyan Yang,Haihua Gu

2022-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].
Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

Zhi Xin,Cui Jin,Liu Chao,Zhang Zheng,Cao Liehu,Pan Panpan,Weng Weizong,Zhai Xiao,Zhao Qingjie,Hu Honggang,Qin Longjuan,Chen Xiao,Su Jiacan

DOI: https://doi.org/10.3389/fphar.2021.605592

IF: 5.6

2021-03-29

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2018.00022.].

pharmacology & pharmacy
Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Huijuan Liu,Honglian Tao,Hongqi Wang,Yuyan Yang,Ru Yang,Xintong Dai,Xiujuan Ding,Haidong Wu,Shuang Chen,Tao Sun

DOI: https://doi.org/10.3389/fonc.2022.830506

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.619317.].

oncology

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

[Corrigendum] Dihydroartemisinin Suppresses Proliferation, Migration, the Wnt/β‑catenin Pathway and EMT Via TNKS in Gastric Cancer

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Correction: Corrigendum: Dihydroartemisinin Prevents Breast Cancer-Induced Osteolysis Via Inhibiting Both Breast Cancer Cells and Osteoclasts

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Corrigendum to “Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2”

Correction: Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer